Cargando…
Supercomputer Search for the New Inhibitors of the Coagulation Factor XIIa
A virtual structure-oriented screening of candidates for inhibitors of blood coagulation factor XIIa was carried out. This coagulation factor is one of the most promising therapeutic targets for the development of anticoagulants without disturbing normal hemostasis. The screening was carried out in...
Autores principales: | Sulimov, A. V., Kutov, D. C., Ilin, I. S., Tashchilova, A. S., Shikhaliev, Kh. S., Sulimov, V. B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pleiades Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9362379/ http://dx.doi.org/10.1134/S199508022207023X |
Ejemplares similares
-
New Blood Coagulation Factor XIIa Inhibitors: Molecular Modeling, Synthesis, and Experimental Confirmation
por: Tashchilova, Anna, et al.
Publicado: (2022) -
Supercomputing, Docking and Quantum Mechanics in Quest for Inhibitors of Papain-like Protease of SARS-CoV-2
por: Sulimov, A. V., et al.
Publicado: (2021) -
Synthesis, Docking, and In Vitro Anticoagulant Activity Assay of Hybrid Derivatives of Pyrrolo[3,2,1-ij]Quinolin-2(1H)-one as New Inhibitors of Factor Xa and Factor XIa
por: Novichikhina, Nadezhda, et al.
Publicado: (2020) -
New Chemicals Suppressing SARS-CoV-2 Replication in Cell Culture
por: Sulimov, Alexey, et al.
Publicado: (2022) -
New Hybrid Tetrahydropyrrolo[3,2,1-ij]quinolin-1-ylidene-2-thioxothiazolidin-4-ones as New Inhibitors of Factor Xa and Factor XIa: Design, Synthesis, and In Silico and Experimental Evaluation
por: Novichikhina, Nadezhda P., et al.
Publicado: (2023)